GlassScriptPhysician profile
Warren L Reidel
NPI 1942272976
$1,815.37
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,765 · 2020: $39.21 · 2021: $11.33.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $495.01 | 2019 | |
| Abbvie INC. | $371.09 | 2019-2020 | |
| Pfizer INC. | $131.60 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $118.86 | 2019 | |
| Intercept Pharmaceuticals, INC. | $108.33 | 2019 | |
| Ucb, INC. | $107.26 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $86.75 | 2019 | |
| Ferring Pharmaceuticals INC. | $65.25 | 2019-2020 | |
| Romark Laboratories, Lc | $57.44 | 2019 | |
| Allergan, INC. | $49.36 | 2019 | |
| Janssen Biotech, INC. | $49.13 | 2019 | |
| Shionogi INC | $45.28 | 2019 | |
| Merck Sharp & Dohme LLC | $31.27 | 2019 | |
| Vivus LLC | $19.26 | 2019 | |
| Ironwood Pharmaceuticals, INC | $15.14 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $14.57 | 2019 | |
| Gilead Sciences, INC. | $13.28 | 2019 | |
| Daiichi Sankyo INC. | $12.65 | 2019 | |
| Qol Medical, LLC | $12.51 | 2019 | |
| Pentax of America, INC. | $11.33 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Reidel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.